Skip to search boxSkip to navigationSkip to main content

Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1β

  • Andreas Papapetropoulos
    ,
  • Gamal Abou-Mohamed
    ,
  • Nandor Marczin
    ,
  • Ferid Murad
    ,
  • R. William Caldwell
    ,
  • John D. Catravas(corresponding author)
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

1 Induction of nitric oxide synthase (iNOS) results in overproduction of nitric oxide (NO), which may be a principal cause of the massive vasodilatation and hypotension observed in septic shock. Since NO-induced vasorelaxation is mediated via the soluble isoform of guanylate cyclase (sGC), the regulation of sGC activity during shock is of obvious importance, but yet poorly understood. The aim of the present study was to investigate the activation of sGC by sodium nitroprusside (SNP) before and after exposure of rat aortic smooth muscle cells to endotoxin (LPS) or interleukin-1β (IL-1β). 2 Exposure of rat aortic smooth muscle cells to SNP (10 μM) elicited up to 200 fold increases in cyclic GMP. This effect was attenuated by 30-70% in IL-1β- or LPS-pretreated cells, in a pretreatment time- and IL-1β- or LPS-concentration-dependent manner. When, however, cells were exposed to IL-1β or LPS and then stimulated with the particulate guanylate cyclase activator, atriopeptin II, no reduction in cyclic GMP accumulation was observed. 3 Pretreatment of rats with LPS (5 mg kg-1, i.v.) for 6 h led to a decrease in aortic ring SNP-induced cyclic GMP accumulation. 4 The IL-1β-induced reduction in SNP-stimulated cyclic GMP accumulation in cultured cells was dependent on NO production, as arginine depletion abolished the downregulation of cyclic GMP accumulation in response to SNP. 5 Reverse-transcriptase-polymerase chain reaction analysis revealed that the ratio of steady state mRNA for the α1 subunit of sGC to glyceraldehyde phosphate dehydrogenase was decreased in LPS- or IL-1β-treated cells, as compared to vehicle-treated cells. 6 Protein levels of the α1 sGC subunit remained unaltered upon exposure to LPS or IL-1β, suggesting that the early decreased cyclic GMP accumulation in IL-1β- or LPS-pretreated cells was probably due to reduced sGC activation. Thus, the observed decreased responsiveness of sGC to NO stimulation following cytokine or LPS challenge may represent an important homeostatic mechanism to offset the extensive vasodilatation seen in sepsis.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1359-1366 (8 pages)

Journal (Volume, Issue Number)

British Journal of Pharmacology (Volume 118, Issue 6)

Publication milestones

  • Published - 1996

Publication status

Published - 1996

ISSN

0007-1188

Publication IDs

  • Scopus: 0029991814
  • PubMed: 8832057

Publication metrics

Metrics

Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1
SciVal
citations
78
SciVal
FWCI
2.27
SciVal
Author count
6
SciVal
Paper percentile
92
SciVal
Top percentile
10
Scopus
citations

PlumX, opens in new tab

Captures
19
Citation count
78

Funding Details

FunderFunding number
NHLBI
R01HL052958